Skip to main content
Sparge Chem Logo
Sparge Chem
"Passion For Innovation"
* Research Use Only

Documents

COA
SDS / Safety Data

Butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate

CAS No.:
Cat. No.: SC251035
Available on Request

Price on Request

Contact us for pricing, MOQ, and lead time

Bulk Inquiry
Product Name :Butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate
Cat. No.: :SC251035
Purity / Specification :—
CAS No. :477775-14-7
MDL No. :—
Molecular Formula :C23H29N3O4S2
LogP :5.30
Molecular Weight :475.62
TPSA :127.0
Category :API Impurities
HSN Code :—
SMILES Code :CCCCOC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C=CN=C3
Melting Point :—
InChI Key : :XTEOJPUYZWEXFI-UHFFFAOYSA-N
Boiling Point :No data available

Application Note

AI Generated

Generated by AI. Verify before use in regulatory documents.

Lipinski & ADMET Properties

Computational estimate

Lipinski Rule of 5

i
✗ FAIL
MW ≤ 500 Da✓ 475.6 Da
LogP ≤ 5✗ 5.30
HBD ≤ 5✓ 1
HBA ≤ 10✓ 6

Max 1 violation allowed for oral bioavailability.

Drug-likeness Score

i
42/100

Fragment / low drug-likeness

Predicted LogP

i
5.30log units

Highly lipophilic

CNS Permeability

i

Clark model · J Pharm Sci, 1999

CNS− unlikely

TPSA 127.0Ų · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−

Requires experimental confirmation.

⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.